Hemab Therapeutics Holdings Common Stock Total Current Liabilities

Hemab Therapeutics Holdings Common Stock (COAG) currently reports a total current liabilities of $13M as of March 2026. Use the charts on this page to explore Hemab Therapeutics Holdings Common Stock's total current liabilities history and peer comparisons.

Hemab Therapeutics Holdings Common Stock reported $13M in total current liabilities as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemab Therapeutics Holdings Common Stock, and consider following COAG for alerts when major investors trade the stock.

Hemab Therapeutics Holdings Common Stock is classified in the Healthcare sector. On total current liabilities, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COAG with unrelated industries.